Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$193.32K

Rothblatt Martine A Chairperson & CEO

Transaction date Aug 7, 2026
Public filing date Aug 10, 2026
Filing lag Filed 3 days later

UTHR daily price context

Close on/before transaction
$538.84 Aug 7, 2026
First close after public filing
$515.5 Aug 11, 2026
30-day return after filing
-1.68% Through Sep 9, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
360 shares @ $536.99
SEC ownership
Indirect
Transaction code
S
Form
4
Filing identifier
0001106578-26-000116
Filing cohort

Transactions in this filing

Showing 15 of 17
Trades
17
Issuers
1
Estimated value
$6.33M
Buys / sales
0 / 15
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Sale Aug 7, 2026 $187.53K
United Therapeutics Corp UTHR Sale Aug 7, 2026 $585.08K
United Therapeutics Corp UTHR Sale Aug 7, 2026 $375.16K
United Therapeutics Corp UTHR Sale Aug 7, 2026 $1.48M
United Therapeutics Corp UTHR Sale Aug 7, 2026 $97.36K
United Therapeutics Corp UTHR Sale Aug 7, 2026 $106.85K
United Therapeutics Corp UTHR Sale Aug 7, 2026 $64.84K
United Therapeutics Corp UTHR Exercise Aug 7, 2026 $0
United Therapeutics Corp UTHR Exercise Aug 7, 2026 $1.29M
United Therapeutics Corp UTHR Sale Aug 7, 2026 $85.34K
United Therapeutics Corp UTHR Sale Aug 7, 2026 $85.65K
United Therapeutics Corp UTHR Sale Aug 7, 2026 $216.52K
United Therapeutics Corp UTHR Sale Aug 7, 2026 $768.96K
United Therapeutics Corp UTHR Sale Aug 7, 2026 $336.59K
United Therapeutics Corp UTHR Sale Aug 7, 2026 $340.74K